LPL Financial’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.9M Buy
1,052,249
+204,211
+24% +$11.1M 0.01% 1064
2026
Q1
$53.2M Sell
848,038
-857,789
-50% -$68.6M 0.01% 885
2025
Q4
$163M Buy
1,705,827
+34,717
+2% +$3.4M 0.04% 379
2025
Q3
$163M Buy
1,671,110
+66,669
+4% +$6.9M 0.05% 357
2025
Q2
$172M Buy
1,604,441
+480,430
+43% +$48.6M 0.06% 311
2025
Q1
$113M Buy
1,124,011
+4,994
+0.4% +$503K 0.04% 379
2024
Q4
$100M Buy
1,119,017
+129,019
+13% +$11.4M 0.04% 403
2024
Q3
$83M Sell
989,998
-25,689
-3% -$2.03M 0.04% 437
2024
Q2
$78.2M Buy
1,015,687
+61,350
+6% +$4.49M 0.04% 420
2024
Q1
$65.4M Buy
954,337
+600,250
+170% +$38.6M 0.04% 456
2023
Q4
$20.5M Sell
354,087
-8,505
-2% -$454K 0.01% 869
2023
Q3
$19.1M Buy
362,592
+17,463
+5% +$916K 0.01% 827
2023
Q2
$18.7M Buy
345,129
+53,627
+18% +$2.8M 0.01% 825
2023
Q1
$14.6M Buy
291,502
+49,283
+20% +$2.32M 0.01% 899
2022
Q4
$11.2M Buy
242,219
+4,746
+2% +$206K 0.01% 964
2022
Q3
$9.2M Sell
237,473
-4,797
-2% -$192K 0.01% 1007
2022
Q2
$9.03M Buy
242,270
+31,646
+15% +$1.29M 0.01% 1021
2022
Q1
$9.33M Sell
210,624
-16,350
-7% -$709K 0.01% 1045
2021
Q4
$9.64M Sell
226,974
-19,853
-8% -$834K 0.01% 1040
2021
Q3
$10.7M Sell
246,827
-253
-0.1% -$11.2K 0.01% 920
2021
Q2
$10.6M Buy
247,080
+37,176
+18% +$1.56M 0.01% 881
2021
Q1
$8.11M Buy
209,904
+32,803
+19% +$1.24M 0.01% 942
2020
Q4
$6.37M Sell
177,101
-11,100
-6% -$400K 0.01% 984
2020
Q3
$7.19M Buy
188,201
+1,640
+0.9% +$63.2K 0.01% 779
2020
Q2
$6.55M Buy
186,561
+21,365
+13% +$769K 0.01% 752
2020
Q1
$5.39M Buy
165,196
+26,879
+19% +$1.05M 0.01% 720
2019
Q4
$6.25M Buy
138,317
+9,860
+8% +$413K 0.01% 748
2019
Q3
$5.23M Buy
128,457
+8,214
+7% +$348K 0.01% 781
2019
Q2
$5.17M Buy
120,243
+6,988
+6% +$269K 0.01% 778
2019
Q1
$4.35M Sell
113,255
-7,631
-6% -$291K 0.01% 828
2018
Q4
$4.27M Sell
120,886
-56,904
-32% -$2.06M 0.01% 746
2018
Q3
$6.84M Buy
177,790
+25,747
+17% +$899K 0.02% 619
2018
Q2
$4.97M Buy
152,043
+57,084
+60% +$1.72M 0.01% 713
2018
Q1
$2.59M Sell
94,959
-36,690
-28% -$997K 0.01% 970
2017
Q4
$3.26M Buy
131,649
+22,216
+20% +$613K 0.01% 824
2017
Q3
$3.19M Buy
109,433
+15,151
+16% +$418K 0.01% 775
2017
Q2
$2.61M Sell
94,282
-13,934
-13% -$370K 0.01% 799
2017
Q1
$2.7M Buy
108,216
+11,532
+12% +$280K 0.02% 684
2016
Q4
$2.12M Sell
96,684
-3,120
-3% -$68.1K 0.02% 766
2016
Q3
$2.32M Sell
99,804
-7,712
-7% -$184K 0.02% 698
2016
Q2
$2.54M Buy
107,516
+47,810
+80% +$1.03M 0.02% 638
2016
Q1
$1.15M Sell
59,706
-46,418
-44% -$815K ﹤0.01% 1580
2015
Q4
$1.93M Buy
106,124
+45,477
+75% +$815K 0.01% 1201
2015
Q3
$1.03M Buy
60,647
+1,838
+3% +$31.4K 0.01% 1218
2015
Q2
$1.03M Buy
58,809
+6,029
+11% +$108K 0.01% 1344
2015
Q1
$932K Buy
52,780
+11,658
+28% +$184K ﹤0.01% 1403
2014
Q4
$545K Sell
41,122
-53,661
-57% -$686K ﹤0.01% 1707
2014
Q3
$1.12M Sell
94,783
-2,790
-3% -$35.1K 0.01% 1194
2014
Q2
$1.25M Buy
97,573
+17,009
+21% +$221K 0.01% 1170
2014
Q1
$1.09M Sell
80,564
-6,007
-7% -$78.8K 0.01% 1214
2013
Q4
$1.04M Sell
86,571
-448
-0.5% -$5.29K 0.01% 1228
2013
Q3
$1.06M Sell
87,019
-3,206
-4% -$34.7K 0.01% 1155
2013
Q2
$836K Buy
+90,225
New +$765K 0.01% 1231

Other funds holding BSX

LPL Financial's BSX Position: Q2 2026 in Review

LPL Financial increased its Boston Scientific (BSX) stake by 24% in Q2 2026, buying an estimated $11.1M and bringing the position to 1,052,249 shares worth $44.9M. The position accounts for 0.01% of the portfolio, ranked #1064.

LPL Financial first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $172M in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • LPL Financial held 1,052,249 shares of Boston Scientific worth $44.9M as of Q2 2026.
  • LPL Financial bought 204,211 Boston Scientific shares in Q2 2026, an estimated $11.1M.
  • Boston Scientific made up 0.01% of LPL Financial's portfolio in Q2 2026, its #1064 holding.
  • LPL Financial first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
  • LPL Financial's Boston Scientific position peaked at $172M in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.